Sun closing Ranbaxy plant in Ireland

Sun Pharmaceutical will lay off about 70 workers and close a plant in Ireland as it cuts back its manufacturing network following its buyout of Ranbaxy Laboratories last year. Sun had put the plant up for sale last year but was unable to find a buyer. According to the Irish Times, a company statement said the plant would close by the end of the year but the company intends to move some jobs to other facilities in its network. "The Cashel facility closure is being implemented as part of this plan to right size the company's global manufacturing activities," said a statement sent to the newspaper. "We expect to cease operations at Cashel by end of current calendar year." Story | More

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.